Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
07/13/2000 | WO2000024741A3 Dihydropyridine compounds and their use as potassium channel openers |
07/13/2000 | WO2000023091A3 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
07/13/2000 | WO2000023063A3 Methods for inhibiting diabetic complications |
07/13/2000 | WO2000021986A3 Matrix-remodeling genes |
07/13/2000 | WO2000018801A3 Ncam binding compounds |
07/13/2000 | WO2000015204A3 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
07/13/2000 | WO2000008020A3 Tricyclic carboxamides |
07/13/2000 | WO1999058096A9 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
07/13/2000 | DE19900674A1 Bindungspartner für 5-HT5-Rezeptoren zur Migränebehandlung Binding partners for 5-HT5 receptors in migraine treatment |
07/13/2000 | DE19900673A1 Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders |
07/13/2000 | DE19900545A1 Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia |
07/13/2000 | DE19900544A1 Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia |
07/13/2000 | DE19900471A1 Imidazo[4,5c]-pyridin-4-on-derivate Imidazo [4,5c] pyridin-4-one derivatives |
07/13/2000 | DE19845405C2 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
07/13/2000 | CA2358962A1 Process for preparing n6-substituted deaza-adenosine derivatives |
07/13/2000 | CA2358939A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
07/13/2000 | CA2358851A1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
07/13/2000 | CA2358578A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
07/13/2000 | CA2358212A1 Formulations for treating disease and methods of using same |
07/13/2000 | CA2357950A1 Therapeutic phosphodiesterase inhibitors |
07/13/2000 | CA2357874A1 Cyclic compound |
07/13/2000 | CA2357771A1 Imidazo[4,5-c]-pyridine-4-one derivatives |
07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
07/13/2000 | CA2356919A1 Selective inhibitors of mmp-12 |
07/13/2000 | CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
07/13/2000 | CA2355967A1 Astrocytes, their preparation and uses thereof |
07/13/2000 | CA2355302A1 Colchinol derivatives as vascular damaging agents |
07/13/2000 | CA2350946A1 Method of treating sexual disturbances |
07/12/2000 | EP1018516A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
07/12/2000 | EP1018339A1 Therapeutic agent for intractable vasculitis |
07/12/2000 | EP1017980A2 Methods of the identification of pharmaceutically active compounds |
07/12/2000 | EP1017713A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
07/12/2000 | EP1017694A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |
07/12/2000 | EP1017692A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
07/12/2000 | EP1017691A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
07/12/2000 | EP1017677A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
07/12/2000 | EP1017672A1 New npy antagonists |
07/12/2000 | EP1017667A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
07/12/2000 | EP1017658A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
07/12/2000 | EP1017423A1 Cloning pigs using donor nuclei from differentiated cells |
07/12/2000 | EP1017416A1 Treatment of cardiomyopathy |
07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
07/12/2000 | EP1017390A2 Combinations of hmg-coa inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
07/12/2000 | EP1017387A1 Vitronectin receptor antagonist |
07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
07/12/2000 | EP1017383A1 Thrombin inhibitors |
07/12/2000 | EP1017382A1 Biarylalkanoic acids as cell adhesion inhibitors |
07/12/2000 | EP1017379A1 Therapeutic compositions |
07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
07/12/2000 | EP1017376A1 Method of treating heart failure |
07/12/2000 | EP0877734B1 Quinoline and quinazoline compounds useful in therapy |
07/12/2000 | EP0690854B1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
07/12/2000 | CN1259956A Novel 4-Halogenated steroids prepn. method and intermediates, application as medicines and pharmaceutical compositions contg. same |
07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
07/12/2000 | CN1259942A Novel guanidine mimics as factor Xa inhibitors |
07/12/2000 | CN1259940A Crystalline roxifiban |
07/12/2000 | CN1259871A Method of treating chronic progressive vascular scarring diseases |
07/12/2000 | CN1259869A Pharmaceutical compositions contg. cinchonine dichlorhydrate |
07/12/2000 | CN1259378A Oral liquid for restoring hemiplegia |
07/12/2000 | CN1259362A Medicine for treating haemorrhoids and anal fistula radically |
07/12/2000 | CN1259360A Medicine for treating pulmonary hart diseases |
07/12/2000 | CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them |
07/12/2000 | CN1054376C Substituted 1H-imidazoles |
07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
07/12/2000 | CN1054373C Full fluoralkyl-substituted bezoylguanidine prepn. pharmaceutical use of same and pharmaceutical containing same |
07/12/2000 | CN1054372C Amino substituted benzosulfonylurea and -thiorea prepn. and pharmaceutical use of same |
07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
07/11/2000 | US6087483 DNA coding an inositol 1,4,5,-triphosphate binding protein |
07/11/2000 | US6087477 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
07/11/2000 | US6087399 Sulfonamide-substituted compounds, process for their preparation, their use as a medicament or diagnostic, and a medicament comprising them |
07/11/2000 | US6087394 Compositions, apparatus and methods for facilitating surgical procedures |
07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
07/11/2000 | US6087379 Cyclic amine derivatives |
07/11/2000 | US6087373 A serine protease inhibitor for preventing or treating unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis |
07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
07/11/2000 | US6087360 Method of treating heart failure with endothelin antagonists |
07/11/2000 | US6087343 Antisense oligonucleotides targeted to β-1 adrenoceptor and methods of use |
07/11/2000 | US6087330 Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor |
07/11/2000 | US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
07/11/2000 | US6086919 Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
07/11/2000 | US6086866 Anastomosing divided blood vessels in a human or animal by administering around the divided ends of the blood vessels, platelet derived growth factor |
07/11/2000 | US6086865 O-chloracetylcarbamoylfumagillol and interferon; synergistic angiogenesis inhibitory effect |
07/11/2000 | US6085754 Cardiac disease treatment method |
07/06/2000 | WO2000039290A2 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
07/06/2000 | WO2000039176A1 Hydrophilic ampholytic polymer |
07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
07/06/2000 | WO2000039154A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
07/06/2000 | WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors |
07/06/2000 | WO2000039128A1 5ht1 antagonists for antidepressant therapy |
07/06/2000 | WO2000039126A1 Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
07/06/2000 | WO2000039124A1 Thrombin inhibitors |
07/06/2000 | WO2000039118A1 Aromatic amides |